Benzion Friedman - May 18, 2017 Form 4 Insider Report for Cell Source, Inc. (CLCS)

Role
Director, 10%+ Owner
Signature
/s/ Benzion Friedman
Stock symbol
CLCS
Transactions as of
May 18, 2017
Transactions value $
$482,472
Form type
4
Date filed
6/10/2021, 01:50 PM
Next filing
Jul 7, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLCS Common Stock Other $4.05K +5.4K +0.12% $0.75* 4.39M Dec 4, 2017 See footnote F1, F2
transaction CLCS Common Stock Other $5K +6.67K +0.15% $0.75* 4.4M Aug 21, 2018 See footnote F1, F2
transaction CLCS Common Stock Other $4.08K +5.44K +0.12% $0.75* 4.4M Dec 31, 2018 See footnote F1, F2
transaction CLCS Common Stock Other $4.02K +5.36K +0.12% $0.75* 4.41M Jun 26, 2019 See footnote F1, F2
transaction CLCS Common Stock Other $19.3K +25.7K +0.58% $0.75 4.43M Dec 31, 2019 See footnote F1, F2
transaction CLCS Common Stock Other $14.7K +19.5K +0.44% $0.75 4.45M Jun 30, 2020 See footnote F1, F2
transaction CLCS Common Stock Other $14.8K +19.7K +0.44% $0.75 4.47M Dec 29, 2020 See footnote F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLCS Series A Convertible Preferred Stock Award $180K +12K +38.03% $15.00* 43.6K Jul 26, 2017 Common Stock 120K $0.75 See footnote F2, F3, F4
transaction CLCS Series A Convertible Preferred Stock Award $237K +31.6K $7.50* 31.6K May 7, 2019 Common Stock 316K $0.75 See footnote F2, F3
transaction CLCS Director Stock Option (Right to Buy) Award $0 +300K $0.00 300K Aug 19, 2020 Common Stock 300K $0.75 Direct
transaction CLCS Director Stock Option (Right to Buy) Disposed to Issuer $0 -300K -100% $0.00* 0 Aug 20, 2020 Common Stock 300K $0.75 Direct
transaction CLCS Director Stock Option (Right to Buy) Award $0 +300K $0.00 300K Aug 20, 2020 Common Stock 300K $0.75 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Issued as payment-in-kind dividend on Series A Convertible Preferred Stock.
F2 Owned by a company wholly owned by the wife of the reporting person.
F3 The Series A Convertible Preferred Stock has no expiration date.
F4 The reporting person was issued 12,000 shares of Series A Convertible Preferred Stock and a note in the principal amount of $180,000 for an aggregate purchase price of $180,000